Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 617

Similar articles for PubMed (Select 19086374)

2.
3.

Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease.

Popov J, Zhukov O, Ruden S, Zeschmann T, Sferruzza A, Sahud M.

Clin Chem. 2006 Oct;52(10):1965-7. Epub 2006 Aug 3.

4.

[Application of collagen-binding assay for von Willebrand disease].

Zhou J, Jia YQ, Jiang H, Yang YM, Deng CQ.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2004 Jan;35(1):126-9. Chinese.

PMID:
14981837
5.

Evaluation of laboratory methods to improve characterization of dogs with von Willebrand disease.

Burgess HJ, Woods JP, Abrams-Ogg AC, Wood RD.

Can J Vet Res. 2009 Oct;73(4):252-9.

6.

Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?

Favaloro EJ, Thom J, Patterson D, Just S, Dixon T, Koutts J, Baccala M, Rowell J, Baker R.

Thromb Res. 2009 Apr;123(6):862-8. doi: 10.1016/j.thromres.2008.10.008. Epub 2008 Dec 7.

PMID:
19064279
7.

Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease.

Favaloro EJ.

Thromb Haemost. 2010 Nov;104(5):1009-21. doi: 10.1160/TH10-06-0360. Epub 2010 Aug 30.

PMID:
20806123
8.

An enzyme-linked immunosorbent assay (ELISA) for von Willebrand factor antigen (vWf-Ag) in canine plasma.

Slappendel RJ, Frielink RA, Mol JA, Noordzij A, Hamer R.

Vet Immunol Immunopathol. 1992 Jun;33(1-2):145-54.

PMID:
1632075
10.
11.
12.

A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.

Vanhoorelbeke K, Cauwenberghs N, Vandecasteele G, Vauterin S, Deckmyn H.

Semin Thromb Hemost. 2002 Apr;28(2):161-6.

PMID:
11992239
13.

Use of the collagen-binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay.

Riddell AF, Jenkins PV, Nitu-Whalley IC, McCraw AH, Lee CA, Brown SA.

Br J Haematol. 2002 Jan;116(1):187-92.

PMID:
11841416
14.

Performance and utility of a cost-effective collagen-binding assay for the laboratory diagnosis of Von Willebrand disease.

Meiring M, Badenhorst PN, Kelderman M.

Clin Chem Lab Med. 2007;45(8):1068-72.

PMID:
17579568
15.
17.
19.

Binding of von Willebrand factor to collagen by flow cytometry.

Kempfer AC, Silaf MR, Farias CE, Carballo GA, Woods AI, Lazzari MA.

Am J Clin Pathol. 1999 Mar;111(3):418-23.

PMID:
10078119
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk